Related Experiment Video
Updated: May 29, 2026
06:57
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Clinical validation of the cobas 4800 HPV test for cervical screening purposes
D A M Heideman1, A T Hesselink, J Berkhof
1Department of Pathology, VU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. dam.heideman@vumc.nl
Journal of Clinical Microbiology
|September 2, 2011
Abstract:
This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.
